Immunosuppressive co-treatment with Infliximab and Adalimumab is not superior than anti-TNF monotherapy to prevent treatment failure over time in ulcerative colitis

VIEUJEAN, Sophie; LOUIS, Edouard; REENAERS, Catherine

Poster (Scientific congresses and symposiums)

VIEUJEAN, Sophie; LOUIS, Edouard; REENAERS, Catherine

2018 • 13th Congress of ECCO

Peer reviewed

Permalink
https://hdl.handle.net/2268/236048

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

ECCO P612.pdf

Publisher postprint (1.28 MB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Disciplines :

General & internal medicine

Author, co-author :

VIEUJEAN, Sophie ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de gastroentérologie, hépatologie, onco. digestive

LOUIS, Edouard ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de gastroentérologie, hépatologie, onco. digestive

REENAERS, Catherine ; Centre Hospitalier Universitaire de Liège - CHU > Département de médecine interne > Service de gastroentérologie, hépatologie, onco. digestive

Language :

English

Title :

Immunosuppressive co-treatment with Infliximab and Adalimumab is not superior than anti-TNF monotherapy to prevent treatment failure over time in ulcerative colitis

Publication date :

February 2018

Event name :

13th Congress of ECCO

Event place :

Vienna, Austria

Event date :

du 14 février 2018 au 17 février 2018

Audience :

International

Peer reviewed :

Peer reviewed

Available on ORBi :

since 28 May 2019

Statistics

Number of views

47 (1 by ULiège)

Number of downloads

5 (0 by ULiège)

More statistics